Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Inhaled Fluticasone Furoate in Persistent Asthma
NCT01431950Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of fluticasone in asthma, sponsored by GSK. Started Sep 2011; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01431950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431950.